Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 18
Submit an article Journal homepage
555
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy

Weiqing Wang Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, 197 Ruijin 2nd Road, Shanghai 200025, China+86 21 64370045 ext. 665344; +86 21 64373514; [email protected]
,
Ruifang Bu Wuxi First People's Hospital, 111 Renming Middle Road, Wuxi, Jiangsu 214002, China
,
Qing Su Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China
,
Jianying Liu The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng Street, Nanchang 330006, China
&
Guang Ning Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, 197 Ruijin 2nd Road, Shanghai 200025, China+86 21 64370045 ext. 665344; +86 21 64373514; [email protected]
, MD PhD
Pages 2791-2799 | Published online: 22 Jul 2011

Bibliography

  • Yang W, Lu J, Weng J, Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101
  • Pan XR, Yang WY, Li GW, Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997;20:1664-9
  • Chan JC, Deerochanawong C, Shera AS, Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective. Diabetes Res Clin Pract 2007;75:255-66
  • Asian-Pacific Type 2 Diabetes Policy Group. Type 2 diabetes: practical targets and treatments. 4th edition. Available from: http://www.diabetes.com.au/pdf/Diabetes_TreatmentTargets_FINAL.pdf [Last accessed 14 June 2011]
  • Nathan DM, Buse JB, Davidson MB, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
  • Chan JC, Malik V, Jia W, Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-40
  • Chinese Diabetes Society. The Chinese type 2 diabetes guideline: Chinese diabetes society. Zhonghua Yi Xue Za Zhi 2008;88:1227-45
  • Rodbard HW, Jellinger PS, Davidson JA, Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-59
  • Moses R, Slobodniuk R, Boyages S, Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 1999;22:119-24
  • US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071624.pdf [Last accessed 14 June 2011]
  • American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care 2011;34(Suppl 1):S11-61
  • International Diabetes Federation. Global guideline for type 2 diabetes. Available from: http://www.idf.org/Global_guideline [Last accessed 14 June 2011]
  • Lund SS, Tarnow L, Stehouwer CD, Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab 2007;9:394-407
  • UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS): VIII. Study design, progress and performance. Diabetologia 1991;34:877-90
  • Raskin P. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes. Diabetes Obes Metab 2008;10:1167-77
  • Papa G, Fedele V, Rizzo MR, Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: a randomized, open-label, two-period, cross-over trial. Diabetes Care 2006;29:1918-20
  • Derosa G, Mugellini A, Ciccarelli L, Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors. Clin Ther 2003;25:472-84
  • He J, Gu D, Wu X, Major causes of death among men and women in China. N Engl J Med 2005;353:1124-34
  • Hanefeld M, Fischer S, Julius U, Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia 1996;39:1577-83
  • DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405
  • Tibaldi J. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes. South Med J 2009;102:60-6
  • Esposito K, Giugliano D, Nappo F, Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004;110:214-19
  • Bailey CJ, Del PS, Eddy D, Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract 2005;59:1309-16
  • UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65
  • Stratton IM, Adler AI, Neil HA, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12
  • Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004;27:1535-40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.